Fate-mapping of Erythropoietin-producing Cells in Mouse Models of Hypoxaemia and Renal Tissue Remodelling Reveals Repeated Recruitment and Persistent Functionality

Overview

Journal Acta Physiol (Oxf)

Specialty Physiology

Date 2022 Jan 4

PMID 34982511

Citations 7

Authors

Sophie L Dahl

Svende Pfundstein

Rico Hunkeler

Xingtong Dong

Thomas Knopfel

Patrick Spielmann

Carsten C Scholz

Karen A Nolan

Roland H Wenger

Affiliations

Soon will be listed here.

Abstract

Aim: Fibroblast-like renal erythropoietin (Epo) producing (REP) cells of the corticomedullary border region "sense" a decrease in blood oxygen content following anaemia or hypoxaemia. Burst-like transcription of Epo during tissue hypoxia is transient and is lost during fibrotic tissue remodelling, as observed in chronic kidney disease. The reason for this loss of Epo expression is under debate. Therefore, we tested the hypothesis that REP cell migration, loss and/or differentiation may cause Epo inhibition.

Methods: Using a reporter mouse that allows permanent labelling of active REP cells at any given time point, we analysed the spatiotemporal fate of REP cells following their initial hypoxic recruitment in models of hypoxaemia and renal tissue remodelling.

Results: In long-term tracing experiments, tagged REP reporter cells neither died, proliferated, migrated nor transdifferentiated into myofibroblasts. Approximately 60% of tagged cells re-expressed Epo upon a second hypoxic stimulus. In an unilateral model of tissue remodelling, tagged cells proliferated and ceased to produce Epo before a detectable increase in myofibroblast markers. Treatment with a hypoxia-inducible factor (HIF) stabilizing agent (FG-4592/roxadustat) re-induced Epo expression in the previously active REP cells of the damaged kidney to a similar extent as in the contralateral healthy kidney.

Conclusions: Rather than cell death or differentiation, these results suggest cell-intrinsic transient inhibition of Epo transcription: following long-term dormancy, REP cells can repeatedly be recruited by tissue hypoxia, and during myofibrotic tissue remodelling, dormant REP cells are efficiently rescued by a pharmaceutic HIF stabilizer, demonstrating persistent REP cell functionality even during phases of Epo suppression.

Citing Articles

Intestinal oxygen utilisation and cellular adaptation during intestinal ischaemia-reperfusion injury.

Archontakis-Barakakis P, Mavridis T, Chlorogiannis D, Barakakis G, Laou E, Sessler D Clin Transl Med. 2024; 15(1):e70136.

PMID: 39724463 PMC: 11670310. DOI: 10.1002/ctm2.70136.

The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.

Locatelli F, Del Vecchio L, Elliott S Clin Kidney J. 2023; 16(10):1563-1579.

PMID: 37779852 PMC: 10539216. DOI: 10.1093/ckj/sfad105.

The transcriptional and regulatory identity of erythropoietin producing cells.

Kragesteen B, Giladi A, David E, Halevi S, Geirsdottir L, Lempke O Nat Med. 2023; 29(5):1191-1200.

PMID: 37106166 DOI: 10.1038/s41591-023-02314-7.

Fount, fate, features, and function of renal erythropoietin-producing cells.

Dahl S, Bapst A, Khodo S, Scholz C, Wenger R Pflugers Arch. 2022; 474(8):783-797.

PMID: 35750861 PMC: 9338912. DOI: 10.1007/s00424-022-02714-7.

EPO synthesis induced by HIF-PHD inhibition is dependent on myofibroblast transdifferentiation and colocalizes with non-injured nephron segments in murine kidney fibrosis.

Kobayashi H, Davidoff O, Pujari-Palmer S, Drevin M, Haase V Acta Physiol (Oxf). 2022; 235(4):e13826.

PMID: 35491502 PMC: 9329237. DOI: 10.1111/apha.13826.

References

Broeker K, Fuchs M, Schrankl J, Kurt B, Nolan K, Wenger R . Different subpopulations of kidney interstitial cells produce erythropoietin and factors supporting tissue oxygenation in response to hypoxia in vivo. Kidney Int. 2020; 98(4):918-931. DOI: 10.1016/j.kint.2020.04.040. View

Fuchs M, Broeker K, Schrankl J, Burzlaff N, Willam C, Wagner C . Inhibition of transforming growth factor β1 signaling in resident interstitial cells attenuates profibrotic gene expression and preserves erythropoietin production during experimental kidney fibrosis in mice. Kidney Int. 2021; 100(1):122-137. DOI: 10.1016/j.kint.2021.02.035. View

Sato K, Hirano I, Sekine H, Miyauchi K, Nakai T, Kato K . An immortalized cell line derived from renal erythropoietin-producing (REP) cells demonstrates their potential to transform into myofibroblasts. Sci Rep. 2019; 9(1):11254. PMC: 6677766. DOI: 10.1038/s41598-019-47766-5. View

Maxwell P, Ferguson D, Nicholls L, Johnson M, Ratcliffe P . The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int. 1997; 52(3):715-24. DOI: 10.1038/ki.1997.387. View

Huang L, Chou H, Chen C . Roxadustat attenuates hyperoxia-induced lung injury by upregulating proangiogenic factors in newborn mice. Pediatr Neonatol. 2021; 62(4):369-378. DOI: 10.1016/j.pedneo.2021.03.012. View

Yamazaki S, Souma T, Hirano I, Pan X, Minegishi N, Suzuki N . A mouse model of adult-onset anaemia due to erythropoietin deficiency. Nat Commun. 2013; 4:1950. DOI: 10.1038/ncomms2950. View

Reinert R, Kantz J, Misfeldt A, Poffenberger G, Gannon M, Brissova M . Tamoxifen-Induced Cre-loxP Recombination Is Prolonged in Pancreatic Islets of Adult Mice. PLoS One. 2012; 7(3):e33529. PMC: 3314663. DOI: 10.1371/journal.pone.0033529. View

Souma T, Suzuki N, Yamamoto M . Renal erythropoietin-producing cells in health and disease. Front Physiol. 2015; 6:167. PMC: 4452800. DOI: 10.3389/fphys.2015.00167. View

Imeri F, Nolan K, Bapst A, Santambrogio S, Abreu-Rodriguez I, Spielmann P . Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype. Kidney Int. 2018; 95(2):375-387. DOI: 10.1016/j.kint.2018.08.043. View

10.

Sato K, Kumagai N, Suzuki N . Alteration of the DNA Methylation Signature of Renal Erythropoietin-Producing Cells Governs the Sensitivity to Drugs Targeting the Hypoxia-Response Pathway in Kidney Disease Progression. Front Genet. 2019; 10:1134. PMC: 6863978. DOI: 10.3389/fgene.2019.01134. View

11.

Chang Y, Yang C, Pan S, Chou Y, Chang F, Lai C . DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys. J Clin Invest. 2016; 126(2):721-31. PMC: 4731189. DOI: 10.1172/JCI82819. View

12.

Wenger R, Kurtz A . Erythropoietin. Compr Physiol. 2013; 1(4):1759-94. DOI: 10.1002/cphy.c100075. View

13.

Obara N, Suzuki N, Kim K, Nagasawa T, Imagawa S, Yamamoto M . Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. Blood. 2008; 111(10):5223-32. DOI: 10.1182/blood-2007-10-115857. View

14.

Bernhardt W, Wiesener M, Scigalla P, Chou J, Schmieder R, Gunzler V . Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol. 2010; 21(12):2151-6. PMC: 3014028. DOI: 10.1681/ASN.2010010116. View

15.

Farsijani N, Liu Q, Kobayashi H, Davidoff O, Sha F, Fandrey J . Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin. J Clin Invest. 2016; 126(4):1425-37. PMC: 4811147. DOI: 10.1172/JCI74997. View

16.

Souma T, Nezu M, Nakano D, Yamazaki S, Hirano I, Sekine H . Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling. J Am Soc Nephrol. 2015; 27(2):428-38. PMC: 4731118. DOI: 10.1681/ASN.2014121184. View

17.

Eckardt K, Koury S, Tan C, Schuster S, Kaissling B, Ratcliffe P . Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney Int. 1993; 43(4):815-23. DOI: 10.1038/ki.1993.115. View

18.

Del Balzo U, Signore P, Walkinshaw G, Seeley T, Brenner M, Wang Q . Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease. J Pharmacol Exp Ther. 2020; 374(2):342-353. DOI: 10.1124/jpet.120.265181. View

19.

Souma T, Yamazaki S, Moriguchi T, Suzuki N, Hirano I, Pan X . Plasticity of renal erythropoietin-producing cells governs fibrosis. J Am Soc Nephrol. 2013; 24(10):1599-616. PMC: 3785278. DOI: 10.1681/ASN.2013010030. View

20.

Bapst A, Dahl S, Knopfel T, Wenger R . Cre-mediated, loxP independent sequential recombination of a tripartite transcriptional stop cassette allows for partial read-through transcription. Biochim Biophys Acta Gene Regul Mech. 2020; 1863(8):194568. DOI: 10.1016/j.bbagrm.2020.194568. View